Last updated on August 2018

Efficacy Safety and Tolerability of CG428 Cutaneous Solution on Chemotherapy Induced Alopecia; Controlled Study (ELAN)

Brief description of study

Phase II clinical trial

Detailed Study Description

The aim of this trial is to compare the degree of efficacy, safety and tolerability of CG 428 cutaneous solution versus placebo on prevention of chemotherapy induced alopecia (CIA) in female patients with metastatic cancer treated with selected regimens inducing alopecia.

Clinical Study Identifier: NCT02919735

Contact Investigators or Research Sites near you

Start Over

Khalil KZ ZAMAN, PhD

CHUV Lausanne
Lausanne, Switzerland

Recruitment Status: Closed

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.